Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Robert Pyke"'
Publikováno v:
Sexual Medicine, Vol 5, Iss 2, Pp e73-e83 (2017)
Introduction: Counts of satisfying sexual events (SSEs) per month have been criticized as an end point in treatment trials of women with hypoactive sexual desire disorder (HSDD) but grounding improvement in sexual desire by assessing changes in sexua
Externí odkaz:
https://doaj.org/article/73ab1ea502574eb2961ca4436d98bfe8
Autor:
Robert Pyke
Publikováno v:
Lifelines 2022.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4665b56c778e609186e87e345e9ee75a
https://doi.org/10.1061/9780784484432.004
https://doi.org/10.1061/9780784484432.004
Autor:
Robert Pyke
Publikováno v:
Sexual Medicine Reviews. 9:186-193
Introduction In 2000, the FDA began issuing advice about treatments for hypoactive sexual desire disorder (HSDD) in women. How its recommendations have evolved has not been reviewed. Its consistent preference for self-rating by patients over evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a941d2d59af3984b028744508e008a
https://doi.org/10.1016/j.sxmr.2020.12.001
https://doi.org/10.1016/j.sxmr.2020.12.001
Autor:
Robert Pyke
Publikováno v:
Sexual Medicine Reviews. 8:183-190
Introduction Sexual performance anxiety (SPA) is one of the most prevalent sexual complaints; yet, no diagnosis is recognized for either gender. Thus, research into treatment has been minimal. Aim Review the prevalence of SPA and its relation to sexu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca210659cb573e1c406ab20f9cbacec8
https://doi.org/10.1016/j.sxmr.2019.07.001
https://doi.org/10.1016/j.sxmr.2019.07.001
Autor:
Robert Pyke
Publikováno v:
Sexual Medicine Reviews. 8:206-216
Introduction Treatment of hypoactive sexual desire disorder (HSDD) remains unfulfilled. The only approved medication, flibanserin (FLI), is highly underused owing to concerns about central nervous system (CNS) depression and interactions. Trazodone (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c1707ff806a59567d4e40757d46932
https://doi.org/10.1016/j.sxmr.2018.08.003
https://doi.org/10.1016/j.sxmr.2018.08.003
Publikováno v:
PEARC
With the increasing popularity of computational approaches to conduct social science research, building a scalable and efficient computing platform has become a topic of interest for academia to empower research labs and institutes to analyze large-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a85678f10ba246157e5a13876a455b3
https://doi.org/10.1145/3437359.3465591
https://doi.org/10.1145/3437359.3465591
Autor:
Robert Pyke, Anita H. Clayton
Publikováno v:
The Journal of Sexual Medicine. 16:1885-1894
Introduction Prior medication treatment for hypoactive sexual desire disorder (HSDD) in women has left about half the subjects without benefit. Lorexys (LOR), a proprietary combination of the stimulating/excitatory dopamine-norepinephrine reuptake in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8f494dc794da2af9ac3ec1b629b5ae
https://doi.org/10.1016/j.jsxm.2019.09.005
https://doi.org/10.1016/j.jsxm.2019.09.005
Autor:
Robert Pyke
Publikováno v:
Geomechanical Modelling in Engineering Practice ISBN: 9780203753583
Geomechanical Modelling in Engineering Practice
Geomechanical Modelling in Engineering Practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60644c9aa5365eb643fb45e148740af9
https://doi.org/10.1201/9780203753583-8
https://doi.org/10.1201/9780203753583-8
Autor:
Robert Pyke, Anita H. Clayton
Publikováno v:
Sexual Medicine Reviews. 6:367-383
Background The Female Sexual Function Index–desire subscale is the standard measure for clinical trials of hypoactive sexual desire disorder (HSDD), but lacks items assessing sexually related behaviors and attitudes toward partner. Counting satisfy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6049cb3f921865d47a4eb2d077e35247
https://doi.org/10.1016/j.sxmr.2017.11.008
https://doi.org/10.1016/j.sxmr.2017.11.008
Autor:
William A. Fisher, Robert Pyke
Publikováno v:
Sexual Medicine Reviews. 5:445-460
Introduction Flibanserin is a postsynaptic 5-HT-1A agonist and 5-HT-2A antagonist for the treatment of generalized acquired hypoactive sexual desire disorder in premenopausal women. Aim To review and evaluate the efficacy and safety of flibanserin. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b18dc9a2efd0dbec126b2aa98ba926
https://doi.org/10.1016/j.sxmr.2017.05.003
https://doi.org/10.1016/j.sxmr.2017.05.003